Regarding Clathrin-Coated Pits and Endocytosis, Bigger Isn't Better by Scherer, Erin
March 19, 2012 SCIENCE SPOTLIGHT 
 
1 Volume 2, Issue 3 | Fred Hutchinson Cancer Research Center 
 
Regarding Clathrin-Coated Pits and Endocytosis, 
Bigger Isn't Better 
March 19, 2012 
       EM Scherer 
Endocytosis is a primary means by which nutrients, cellular surface receptors (e.g., signaling and 
adhesion molecules) and even other cells are brought into a cell. Multiple endocytic pathways exist, 
including caveolar endocytosis, phagocytosis, pinocytosis and clathrin-mediated endocytosis (CME). 
CME requires adaptor proteins to mediate the recruitment of specific receptors to clathrin-coated 
pits. The primary adaptor protein for CME, AP2, employs different domains to coordinate the binding 
of membrane phospholipids, receptors, clathrin and accessory proteins that close and detach the 
clathrin-coated pit from the plasma membrane. AP2 also binds other adaptor proteins, such as ARH, 
a low-density lipoprotein receptor (LDLR) adaptor protein, thus expanding the cargo that can be 
directly or indirectly internalized via AP2. 
In 2006, former graduate student Dr. Meghan Maurer and advisor Dr. Jonathan Cooper of the Basic 
Sciences Division found that LDLR could be endocytosed via an alternate pathway in human 
fibroblasts that utilizes the clathrin-associated adaptor protein, Disabled-2 (Dab2). However, unlike 
ARH, Dab2 can efficiently recruit LDLR into clathrin-coated pits in the absence of AP2. To 
understand how this Dab2-dependent LDLR endocytosis pathway operates, current graduate 
student Erin Mulkearns and Jon Cooper initiated a focused search for accessory proteins that assist 
Dab2-directed endocytosis. Using mass spectrometry to identify proteins that specifically associate 
with Dab2 in HeLa cells, they detected a novel Dab2-interacting protein, FCHO2, which is an 
accessory protein that binds to and manipulates membranes. Mulkearns showed that both FCHO2 
and AP2 interact with the same region of Dab2. Moreover, the Dab2/FCHO2 interaction was 
required for efficient LDLR internalization when AP2 was depleted from HeLa cells. The authors also 
found that when FCHO2 expression was downregulated, clathrin-coated structures decreased in 
number, but increased in size, and LDLR internalization was reduced by 50 percent. However, 
efficient endocytosis of LDLR by both AP2 and Dab2 pathways could be rescued if low temperatures 
were employed to slow clathrin-coated pit budding and promote LDLR accumulation in FCHO2-
depleted clathrin-coated structures. This novel finding suggests that FCHO2 regulates the size of 
clathrin-coated structures and their ability to trap receptors, both of which are essential aspects of 
CME. 
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In HeLa cells that stably express a labeled form of LDL 
receptor (LDLR, green stain), Dab2 (red) recruits LDLR into 
clathrin-coated structures (yellow, merge). However, in 
cells treated with siRNA against FCHO2 mRNA to 
downregulate FCHO2 expression (bottom panels), clathrin-
coated structures are fewer and larger in size, and LDLR 
recruitment into these structures is less efficient, thus 
reducing the amount of LDLR/Dab2 co-staining. (Scale bar 
is 10 micrometers.) 
 
